CARTITUDE-1 final results: Phase 1b/2 study of ciltacabtagene autoleucel in heavily pretreated patients with relapsed/refractory multiple myeloma Meeting Abstract
| Authors: | Lin, Y.; Martin, T.; Usmani, S.; Berdeja, J.; Jakubowiak, A.; Agha, M.; Cohen, A.; Deol, A.; Htut, M.; Lesokhin, A.; Munshi, N.; O'Donnell, E.; Jackson, C.; Yeh, T. M.; Banerjee, A.; Zudaire, E.; Madduri, D.; delCorral, C.; Pacaud, L.; Jagannath, S. |
| Abstract Title: | CARTITUDE-1 final results: Phase 1b/2 study of ciltacabtagene autoleucel in heavily pretreated patients with relapsed/refractory multiple myeloma |
| Meeting Title: | 11th Annual Meeting of the Society of Hematologic Oncology (SOHO 2023): Progress in Personalized Therapy |
| Keywords: | multiple myeloma; phase i/ii; car-t cell therapy; cilta-cel |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 23 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Sep 6-9 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-09-01 |
| Start Page: | S488 |
| End Page: | S489 |
| Language: | English |
| ACCESSION: | WOS:001062479600566 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(23)01433-7 |
| Notes: | Meeting Abstract: MM-309 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work